EMILY ARNOLD: Open Payments
NPI 1861186181 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 35 payments from 11 companies in 2025. Trend: 2023 $559 · 2024 $307 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $285 |
| E.R. Squibb & Sons, L.L.C. | 4 | $158 |
| Janssen Pharmaceuticals, Inc | 4 | $97 |
| Lundbeck LLC | 3 | $90 |
| Teva Pharmaceuticals USA, Inc. | 5 | $85 |
| ABBVIE INC. | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Corium, LLC | 1 | $16 |
Products named: Auvelity, COBENFY, REXULTI, VRAYLAR, INVEGA SUSTENNA, UZEDY, SPRAVATO, AUSTEDO XR.
Industry payments across AR — which companies pay providers there.
